Skip to main content
Accounting, Audit & Ind AS

Ind AS 20 – Accounting for Government Grants & Disclosure of Government Assistance

Content updated 21 October 2026. Dates, reporting basis and sources are stated beside the revised examples.

Page content

Ind AS 20 – Government Grants
📊 Company data: FY2024–25 ⏱ 14 min read 🏛 MCA Notified Standard Sources checked: 21 October 2026

Reviewed by CA Nikhil Gupta · Last reviewed 4 June 2025

📌 Standard at a Glance: Ind AS 20 prescribes how to account for, and disclose, government grants and government assistance. With India's massive PLI (Production Linked Incentive) schemes, export incentives (RoDTEP, MEIS), and capital subsidies for new industries, Ind AS 20 has become highly relevant for manufacturing, pharma, electronics, and textiles companies.
Find the rule quickly:
  • Scope and definitions: paragraphs 1–3.
  • Recognition and timing: paragraphs 7–12 and 16–22.
  • Non-monetary and asset grants: paragraphs 23–28.
  • Income presentation and repayment: paragraphs 29–33.
  • Government assistance and disclosures: paragraphs 34–39.

Read the current ICAI compendium text. The paragraph references above are to Ind AS 20.

1. What government grants cover

Ind AS 20 covers government resources transferred to an entity in exchange for past or future compliance with conditions. A grant can be cash, an asset or the benefit of a qualifying below-market government loan. Identify what the grant is intended to compensate before choosing its accounting treatment.

Start with the substance of the assistance
TypeKey questionTreatment to consider
Asset-related grantIs the primary condition to acquire or construct a long-term asset?Deferred income or deduction from the asset's carrying amount.
Income-related grantWhich costs or periods does it compensate?Match it systematically to those costs; present separately or offset the related expense.
Forgivable government loanIs there reasonable assurance that forgiveness conditions will be met?Treat as a grant when that test is met; an ordinary soft loan is not automatically forgivable.
Non-monetary grantHas the government transferred an asset such as land?Account for both asset and grant at fair value, or use the permitted nominal-amount alternative.
Other government assistanceCan its value be measured and distinguished from normal trading?Some assistance, such as free advice, calls for relevant disclosure rather than a measurable grant entry.
Scope matters: income-tax benefits determined through taxable profit, tax loss or income-tax liability are outside Ind AS 20. Government ownership participation and grants covered by Ind AS 41 are also excluded. A credit administered through a tax system is not automatically an income-tax benefit: check how the entitlement is calculated. See Ind AS 20 paragraphs 2–3.

2. When to recognise a grant

Paragraph 7 requires reasonable assurance of both compliance with the attached conditions and receipt of the grant. An application, scheme approval or even cash received does not by itself prove both conditions. “Virtually certain” is not the Ind AS 20 recognition threshold.

  1. Read the scheme's eligibility, investment, production, sales and continuing conditions.
  2. Record the evidence supporting reasonable assurance of compliance and receipt.
  3. Identify the costs or periods being compensated, then recognise the grant systematically with those expenses.
  4. Reassess changes in conditions, recovery or repayment obligations.

Grants compensating costs already incurred, or providing immediate support without future related costs, are recognised in profit or loss when they become receivable (paragraphs 20–22). A multi-year scheme does not automatically require equal annual income or recognition only when cash arrives.

3. Asset-related grants: two presentation methods

Paragraphs 24–27 permit deferred income or deduction from the asset's carrying amount. The standard does not designate one method as preferred. Disclose the policy and apply it consistently to similar grants.

Illustrative inputs: plant cost ₹200 lakh; qualifying grant ₹50 lakh; useful life 20 years; straight-line depreciation, no residual value and a full year's use. These assumed amounts are not company disclosures.
ItemDeferred incomeAsset deduction
Initial asset amount₹200 lakh₹150 lakh after grant deduction
Initial deferred grant₹50 lakhNone
Annual depreciation₹10 lakh₹7.5 lakh
Annual grant release₹2.5 lakhReflected in lower depreciation
Net annual profit-or-loss charge₹7.5 lakh₹7.5 lakh
Asset deduction method: show the separate transactions (₹lakh)
Dr Plant 200 / Cr Bank or supplier 200
Dr Bank or grant receivable 50 / Cr Plant 50
Dr Depreciation expense 7.5 / Cr Accumulated depreciation 7.5

The net presentation does not mean that only ₹150 lakh was paid to the supplier. Paragraph 28 explains why gross asset purchases and grant receipts may be shown separately in cash-flow information.

4. Income-related grants

Recognise income-related grants with the costs they compensate. Paragraphs 29–31 permit a separate credit, a general heading such as other income, or a deduction from the related expense. The actual presentation in a company's report must be checked; grants are not universally reported in other income.

Illustrative expense grant: ₹12 lakh earned and reasonably assured
Dr Grant receivable ₹12 lakh
Cr Grant income ₹12 lakh
Alternatively, credit the related expense under the adopted policy. When cash is collected, debit bank and credit the receivable; do not recognise the income twice.

5. Applying the rules to PLI schemes

Production Linked Incentive arrangements have scheme-specific conditions. A company must assess its own eligible products, thresholds, approvals and continuing obligations. Classify assistance by its substance; a scheme's name does not replace that assessment.

QuestionPractical answer
Is approval enough?No. Test compliance and receipt separately. Dixon's FY25 IT-hardware example below illustrates approval without meeting the criteria at the reporting date.
Must the claim be paid first?No universal cash-only rule applies. Use the reasonable-assurance test and match the related costs. A later approval may affect when assurance is established.
Is every pending claim a contingent asset?No. A recognised receivable can remain unpaid. Where recognition criteria are not met, assess the facts and relevant contingent-asset requirements; do not classify by filing status alone.
Where is the receivable shown?Assess the nature of the right and current/non-current criteria. Filing a form does not itself decide financial versus non-financial asset classification.
Which amount is income?Distinguish a gross government claim, amounts transferred to customers, net income retained and cash collected. Reconcile each separately.

6. Non-monetary grants and below-market loans

Land and equipment

Paragraph 23 permits fair-value measurement of both the non-monetary asset and grant, or a nominal amount. Land commonly has an indefinite useful life: do not amortise its grant over an invented “land life.” Where a land grant requires construction of a building or other obligations, recognise income over the periods bearing those costs, as described in paragraph 18.

Worked example: a government loan

Assumptions: receive ₹100 lakh now; pay interest of ₹3 lakh at each year-end for five years; repay ₹100 lakh principal at the end of year 5; comparable market borrowing rate is 10%; no fees. Assume reasonable assurance exists and the benefit compensates future qualifying costs, so it is initially deferred. Paragraph 10A measures the benefit as proceeds less the loan's initial carrying value under Ind AS 109.

Calculate the contractual cash flows (₹lakh)
Initial loan value = Σ[3 ÷ (1.10)^t], t=1…5, + 100 ÷ (1.10)^5
= 73.46449
Grant benefit = 100 − 73.46449 = 26.53551

Dr Bank 100.00000
Cr Loan liability 73.46449
Cr Deferred government grant 26.53551

Round displayed amounts to ₹73.46 lakh and ₹26.54 lakh after calculating. For a loan subsequently measured at amortised cost, first-year effective interest is ₹7.34645 lakh; after the ₹3 lakh coupon, the liability becomes ₹77.81094 lakh. The grant's release follows the costs it compensates; it is not automatically immediate income.

7. Repayment and disposal

A grant that becomes repayable is a change in accounting estimate under paragraph 32. Apply the accounting method already used:

  • Income grant: apply repayment against any unamortised deferred credit first, then charge the excess to profit or loss.
  • Asset grant shown as deferred income: reduce the deferred-income balance by the amount repayable. Do not increase it. Any repayment beyond the available deferred balance requires a profit-or-loss charge.
  • Asset deduction method: increase the asset's carrying amount; recognise immediately the cumulative additional depreciation that would have arisen without the grant. Consider impairment of the resulting carrying amount (paragraph 33).
Illustrative repayment: a ₹2 crore grant is released over a 20-year plant life. After five full years, ₹0.50 crore has been recognised and ₹1.50 crore remains deferred. If the scheme then requires repayment of exactly ₹1.50 crore, debit deferred income and credit the repayment liability or bank by ₹1.50 crore. Do not both release that same balance to income and charge it again as a repayment expense.

Selling an asset does not automatically settle every grant condition. Check continuing obligations and repayment terms before determining the treatment of any remaining deferred balance. Account for the asset disposal using its carrying amount under the applicable asset standard.

8. What three FY25 annual reports actually show

The following amounts are reported facts, not assumptions. Each case identifies its entity basis and source. “FY25” means the year ended 31 March 2025.

Case 1: Dixon Technologies — scheme eligibility and net presentation

FY2024–25, consolidated report; amounts converted from ₹lakh to ₹crore. Dixon's Note 60 separates its subsidiaries' PLI schemes rather than reporting one uniform accounting outcome.

Telecom and networking: Dixon Electro Appliances recognised ₹3,971 lakh (₹39.71 crore), net of benefits transferred to customers, in other operating revenue. The note reports a gross government receivable of ₹12,600 lakh (₹126.00 crore) in other current financial assets.
White goods: Dixon Technologies Solutions recognised ₹1,440 lakh (₹14.40 crore) in other operating revenue after meeting the scheme's FY25 thresholds.
IT hardware PLI 2.0: Padget Electronics had scheme approval, but the report states that its investment and revenue criteria had not been met at 31 March 2025.

What this teaches: scheme approval, income recognition, cash collection and a receivable balance describe different things. Read the conditions for each scheme and distinguish net income retained by the entity from the gross claim. The group's policy uses reasonable assurance, and its expense-related grants may be deducted from related expenditure.

Source: Dixon FY25 annual report filed with NSE, consolidated Note 60(a)–(d), printed pp.400–401 (PDF pp.389–390); policy 7.5. These scheme-specific amounts are not presented as total group PLI income.

Case 2: Sun Pharma — grants in operating revenue and a separate receivable

FY2024–25; the report uses ₹million. Divide a reported million amount by 10 to convert it into ₹crore, and keep consolidated and standalone figures separate.

Consolidated government grants: Note 30 includes ₹4,252.3 million (₹425.23 crore) in other operating revenues, compared with ₹6,342.3 million (₹634.23 crore) in FY24. This covers grants recognised by the parent and its Indian subsidiaries; it is not identified as an export-incentive-only total.
Standalone government grants: Note 30 reports ₹3,379.9 million (₹337.99 crore), compared with ₹4,025.4 million (₹402.54 crore) in FY24.
Export incentives receivable: Note 18 reports ₹84.9 million (₹8.49 crore) at 31 March 2025, versus ₹115.1 million (₹11.51 crore) at 31 March 2024, within other current assets. This closing balance is not annual grant income.

Accounting policy: policy (p) requires reasonable assurance of compliance and receipt, matches expense grants to the relevant costs, and deducts asset grants from the asset's carrying amount. This illustrates the asset deduction method in actual published accounts.

Source: Sun Pharma FY25 annual report, consolidated policy (p), printed p.242; Notes 18 and 30, pp.254 and 257 (PDF pp.244, 256 and 259). Standalone equivalents: pp.164, 176 and 179. The published grant totals do not provide a scheme-by-scheme MEIS/RoDTEP split.

Case 3: Tata Motors — claim-year timing and an actual asset-related grant

FY2024–25, standalone financial statements; ₹crore. The reporting year of incentive income can differ from the production year to which the claim relates.

Government incentives: Note 32(b) reports ₹285 crore in other income in FY25, compared with ₹209 crore in FY24.
PLI detail: the note identifies ₹40 crore recognised in FY25 after approval of the FY24 claim. It separately identifies ₹135 crore of FY25 income on products for which the Techno Commercial Audit had been confirmed. Keep these two scheme years distinct.
EPCG grant balance: Note 30(b) identifies ₹208 crore at 31 March 2025 (₹186 crore in FY24) relating to duty saved on imported capital goods and spares. Prescribed export commitments apply; failure can require repayment of duty saved with interest.

What this teaches: use the actual grant's terms and the company's policy. Note 32(a) matches grants to related costs, defers asset-related grants over the asset's useful life and offsets expense-related grants against related expenditure. A recognised income amount is different from an outstanding deferred-grant balance.

Source: Tata Motors FY25 annual report, standalone Notes 30(b) and 32(a)–(b), printed pp.468–470 (PDF pp.472–474). These figures refer to the FY25 reporting entity and period; later group restructuring does not change their historical basis.

9. AS 12 and Ind AS 20: useful distinctions

AS 12 also permits deferred-income treatment for grants related to depreciable fixed assets. It is incorrect to describe its method as deduction-only.

TopicAS 12Ind AS 20
Depreciable asset grantsDeduct from asset cost or treat as deferred income.Deferred income or asset deduction.
Non-monetary asset grantsAcquisition cost for concessional assets; nominal value if free.Fair value or the permitted nominal-amount alternative.
Promoters' contributionSpecified grants of this nature go to capital reserve.Government grants follow the income approach; government ownership participation is a separate scope issue.
Below-market government loansNo equivalent explicit Ind AS 109 measurement requirement.Measure the benefit under paragraph 10A with Ind AS 109.
Refundable grantsAS 12 has its own refund requirements.Change in accounting estimate; apply paragraph 32.

Sources: MCA AS 12, paragraphs 14–17 and 20–21; ICAI's 2025–26 Ind AS 20 text, paragraphs 10A, 12, 23–32 and Appendix A.

Keep these distinctions clear

  • Reasonable assurance is the grant recognition threshold.
  • Recognition, presentation, collection and a closing receivable are separate assessments.
  • Both asset presentation methods are permitted; disclose the chosen policy.
  • Match grant income to the costs it compensates, including the immediate-support exceptions.
  • Record scheme conditions, unfulfilled obligations and repayment risks.

10. Frequently asked questions

Does PLI always go to other income?

No. Assess the grant's nature and presentation policy. Income grants may be presented separately or offset related expenses. Dixon's scheme-specific disclosures use other operating revenue, while Tata Motors reports government incentives in other income. The reasonable-assurance test applies before recognition.

Can I recognise an unpaid claim as income?

Payment is not the only recognition trigger. Recognise only when there is reasonable assurance of compliance and receipt, then match the grant to the related costs. A pending payment does not automatically make an already recognised claim a contingent asset.

What happens to the grant when the asset is sold?

Check the grant agreement, continuing obligations and any repayment requirement. For a repayable grant, apply paragraph 32 using the existing deferred-income or asset-deduction method. Do not automatically release a balance to income and expense the same repayment again.

Is every tax incentive outside Ind AS 20?

No. Paragraph 2(b) excludes benefits determined through taxable profit, tax loss or income-tax liability. Assess expenditure-based credits and other assistance by their actual terms. A government purchase of ordinary shares and a normal customer contract are separate transactions rather than government grants.

Related Ind AS Articles

Home / Insights / IndAS & Accounting
More on IndAS & Accounting
Browse all IndAS & Accounting articles →
Related Articles
Ind AS 19 – Employee Benefits Ind AS 29 – Hyperinflationary Economies Ind AS 32 & 107 – Financial Instruments Presentation & Disclosures Ind AS 36 – Impairment of Assets Ind AS 37 – Provisions, Contingent Liabilities & Assets

Sources and reporting basis

Standards checked against the ICAI 2025–26 compendium; company examples use annual reports for the year ended 31 March 2025. Source check: 21 October 2026. Reported balances and income amounts are labelled separately.

  1. Ind AS 20 — ICAI compendium: paragraphs 7–12, 18, 20–32 and 39.
  2. AS 12 — MCA text: paragraphs 14–17 and 20–21.
  3. Dixon FY25 report — issuer filing with NSE: consolidated Note 60, printed pp.400–401; policy 7.5. Units: ₹lakh.
  4. Sun Pharma FY25 report: consolidated policy (p), Notes 18 and 30, printed pp.242, 254 and 257; standalone pp.164, 176 and 179. Units: ₹million.
  5. Tata Motors FY25 report: standalone Notes 30(b) and 32, printed pp.468–470. Units: ₹crore.

Use this grant checklist

For each scheme, reconcile the approved amount, income recognised, customer pass-through, receivable, cash collected and deferred balance. Check the reporting year, entity basis and units before comparing companies.

Disclose the accounting policy, nature and extent of recognised assistance, and unfulfilled conditions or contingencies as required by Ind AS 20 paragraph 39.